Top Tweets for #ProjectLivinLabel
HOPA is partnering with @FDAOncology, @AACR and @oncologynursing on #ProjectLivinLabel to foster broad understanding of associated oncology product label and increase awareness of oncology product FDA approvals. Earn ACPEs by reviewing video content here: https://t.co/d6p5CrMSSs

HOPA is partnering with @FDAOncology, @AACR and @oncologynursing on #ProjectLivinLabel to foster broad understanding of associated oncology product label and increase awareness of oncology product FDA approvals. Earn CPEs by reviewing video content here: https://t.co/d6p5CrMSSs

HOPA is partnering with @FDAOncology, @AACR and @oncologynursing on #ProjectLivinLabel to foster broad understanding of associated oncology product label and increase awareness of oncology product FDA approvals. Earn CPEs by reviewing video content here: https://t.co/d6p5CrMSSs

The latest episode of #ProjectLivinLabel provides the backstory fam-trastuzumab deruxtecan-nxki, a treatment for selected patients with unresectable or metastatic HER2-low breast cancer. Watch the episode and earn CME credit:
https://t.co/QC7ENIS70p
@FDAOncology

The latest episode of #ProjectLivinLabel provides the backstory fam-trastuzumab deruxtecan-nxki, a treatment for selected patients with unresectable or metastatic HER2-low breast cancer. Watch the episode and earn CME credit:
https://t.co/6Il8HArnOt
@FDAOncology

The latest episode of #ProjectLivinLabel provides the backstory fam-trastuzumab deruxtecan-nxki, a treatment for selected patients with unresectable or metastatic HER2-low breast cancer. Watch the episode and earn CME credit:
https://t.co/Ntw1hSgi4W
@FDAOncology

The latest episode of #ProjectLivinLabel provides the backstory fam-trastuzumab deruxtecan-nxki, a treatment for selected patients with unresectable or metastatic HER2-low breast cancer. Watch the episode and earn CME credit:
https://t.co/hgXBUZ6SKD
@FDAOncology

Ivosidenib is an IDH1 inhibitor that exploits weaknesses in cancer metabolism. The latest episode of #ProjectLivinLabel highlights the development of this new treatment for acute myeloid leukemia. Watch the episode and earn CME credit:
https://t.co/wucig81DZN
@FDA_Oncology

Ivosidenib is an IDH1 inhibitor that exploits weaknesses in cancer metabolism. The latest episode of #ProjectLivinLabel highlights the development of this new treatment for acute myeloid leukemia. Watch the episode and earn CME credit:
https://t.co/kvCJVYjPt8
@FDA_Oncology

Ivosidenib is an IDH1 inhibitor that exploits weaknesses in cancer metabolism. The latest episode of #ProjectLivinLabel highlights the development of this new treatment for acute myeloid leukemia. Watch the episode and earn CME credit:
https://t.co/J8C5tiKBlf
@FDA_Oncology

Ivosidenib is an IDH1 inhibitor that exploits weaknesses in cancer metabolism. The latest episode of #ProjectLivinLabel highlights the development of this new treatment for acute myeloid leukemia. Watch the episode and earn CME credit:
https://t.co/BjpzOB36iU
@FDA_Oncology

Ivosidenib is an IDH1 inhibitor that exploits weaknesses in cancer metabolism. The latest episode of #ProjectLivinLabel highlights the development of this new treatment for acute myeloid leukemia. Watch the episode and earn CME credit:
https://t.co/KfKmQRyNsc
@FDA_Oncology

Immune checkpoint inhibitors like nivolumab ushered in a new era of treating patients with cancer. The latest episode of #ProjectLivinLabel highlights the story of nivolumab and explores its product label. Watch the episode and earn CME credit:
https://t.co/gWpxWY6bIV

Immune checkpoint inhibitors like nivolumab ushered in a new era of treating patients with cancer. The latest episode of #ProjectLivinLabel highlights the story of nivolumab and explores its product label. Watch the episode and earn CME credit:
https://t.co/gWpxWY6bIV

Immune checkpoint inhibitors like nivolumab ushered in a new era of treating patients with cancer. The latest episode of #ProjectLivinLabel highlights the story of nivolumab and explores its product label. Watch the episode and earn CME credit:
https://t.co/1fSNnqOjGZ

Immune checkpoint inhibitors like nivolumab ushered in a new era of treating patients with cancer. The latest episode of #ProjectLivinLabel highlights the story of nivolumab and explores its product label. Watch the episode and earn CME credit:
https://t.co/BOAR7r5P2y

Immune checkpoint inhibitors like nivolumab ushered in a new era of treating patients with cancer. The latest episode of #ProjectLivinLabel highlights the story of nivolumab and explores its product label. Watch the episode and earn CME credit:
https://t.co/3kOEl7pjUJ

Donβt miss @FDAOncology and @AACRβs #ProjectLivinLabel panel with Greg Friberg, @Amgen's VP of Medical Affairs for Europe, discussing our work to bring a first-in-class targeted therapy to patients with KRAS G12C-mutated non-small cell lung cancer. #LCSM

Project Livinβ Label: Sotorasib
Nicole Drezner of @FDAOncology leads a discussion of the development of sotorasib, an inhibitor that targets the KRAS G12C mutant, for adult patients with locally advanced or metastatic NSCLC. CME credit available:
https://t.co/UKI5JAerhl

Watch #ProjectLivinLabel episodes and get free CME while enjoying lively discussions on recent cancer drug approvals from FDA reviewers, patients, academic oncologists, and company representatives #MedEd #OCEProjectSocrates
https://t.co/HimbivqChZ

Last Seen Hashtags on Sotwe
incestopaiefilha
Seen from Brazil
lamiastagionepreferita
Seen from United States
chub4chaser
NoLimit()
Seen from Mexico
Teenagee nolimit
Hijabi
Seen from India
ΰΈΰΈΰΈΰΉΰΈΰΉΰΈΰΈΰΈ³ΰΈΰΈ₯ΰΈ΄ΰΈ
Seen from Thailand
teenagee #momson
Seen from Japan
ΰΈΰΈ±ΰΈΰΉΰΈ’ΰΉΰΈΰΉΰΈ‘ΰΉΰΈͺΰΈΰΈ
Seen from Thailand
momson() nolimit() +filter:native_video
Most Popular Users

Elon Musk 
@elonmusk
240.8M followers

Barack Obama 
@barackobama
119.2M followers

Donald J. Trump 
@realdonaldtrump
111.7M followers

Cristiano Ronaldo 
@cristiano
111.2M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
97.8M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91M followers

KATY PERRY 
@katyperry
88M followers

Taylor Swift 
@taylorswift13
81.9M followers

Lady Gaga 
@ladygaga
73.4M followers

Virat Kohli 
@imvkohli
70.4M followers

Kim Kardashian 
@kimkardashian
69.9M followers

YouTube 
@youtube
68.7M followers

Bill Gates 
@billgates
64.1M followers

Neymar Jr 
@neymarjr
63.2M followers

The Ellen Show
@theellenshow
62.4M followers

CNN 
@cnn
61.9M followers

Selena Gomez 
@selenagomez
61.1M followers

X 
@x
60.8M followers



